{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:09:02Z","timestamp":1793261342499,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-025-02251-3","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T09:46:23Z","timestamp":1744796783000},"page":"1831-1839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phenotype\u2013genotype correlations in patients with Alport syndrome from the Polish population"],"prefix":"10.1093","volume":"38","author":[{"given":"Maria","family":"Malarska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Moczulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Pachniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Gadzalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Jakiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Gorz\u0105dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Ju\u015bci\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Pietrusi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Mazerant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Pukaj\u0142o-Marczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kili\u015b-Pstrusi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Majos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Podg\u00f3rski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8781-4469","authenticated-orcid":false,"given":"Agnieszka","family":"Zmys\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"issue":"9","key":"2251_CR1","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1681\/ASN.2020071065","volume":"32","author":"J Gibson","year":"2021","unstructured":"Gibson J, Fieldhouse R, Chan MMY et al (2021) Prevalence estimates of predicted pathogenic COL4A3\u2013COL4A5 variants in a population sequencing database and their implications for Alport syndrome. J Am Soc Nephrol 32(9):2273\u20132290. https:\/\/doi.org\/10.1681\/ASN.2020071065","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2251_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10157-018-1629-4","volume":"23","author":"K Nozu","year":"2019","unstructured":"Nozu K, Nakanishi K, Abe Y et al (2019) A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol 23(2):158\u2013168. https:\/\/doi.org\/10.1007\/s10157-018-1629-4","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"2251_CR3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","volume":"93","author":"CE Kashtan","year":"2018","unstructured":"Kashtan CE, Ding J, Garosi G et al (2018) Alport syndrome: a unified classification of genetic disorders of collagen IV \u03b1345: a position paper of the Alport syndrome classification working group. Kidney Int 93(5):1045\u20131051. https:\/\/doi.org\/10.1016\/j.kint.2017.12.018","journal-title":"Kidney Int"},{"issue":"1","key":"2251_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/ng0994-77","volume":"8","author":"T Mochizuki","year":"1994","unstructured":"Mochizuki T, Lemmink HH, Mariyama M et al (1994) Identification of mutations in the \u03b13(IV) and \u03b14(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8(1):77\u201382. https:\/\/doi.org\/10.1038\/ng0994-77","journal-title":"Nat Genet"},{"issue":"27","key":"2251_CR5","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.2174\/0929867328666210108113500","volume":"28","author":"AL Pedrosa","year":"2021","unstructured":"Pedrosa AL, Bitencourt L, Paranhos RM, Leit\u00e1o CA, Ferreira GC, Sim\u00f5es e Silva AC (2021) Alport syndrome: a comprehensive review on genetics, pathophysiology, histology, clinical and therapeutic perspectives. Curr Med Chem 28(27):5602\u20135624. https:\/\/doi.org\/10.2174\/0929867328666210108113500","journal-title":"Curr Med Chem"},{"issue":"3","key":"2251_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0002-9343(81)90571-4","volume":"70","author":"M Gubler","year":"1981","unstructured":"Gubler M, Levy M, Broyer M et al (1981) Alport\u2019s syndrome. Am J Med 70(3):493\u2013505. https:\/\/doi.org\/10.1016\/0002-9343(81)90571-4","journal-title":"Am J Med"},{"key":"2251_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.766224","volume":"8","author":"X Zhou","year":"2021","unstructured":"Zhou X, Wang J, Mao J, Ye Q (2021) Clinical manifestations of Alport syndrome-diffuse leiomyomatosis patients with contiguous gene deletions in COL4A6 and COL4A5. Front Med 8:766224. https:\/\/doi.org\/10.3389\/fmed.2021.766224","journal-title":"Front Med"},{"key":"2251_CR8","volume-title":"Interna Szczeklika","year":"2022","unstructured":"Szczeklik A (ed) (2022) Interna Szczeklika. Medycyna Praktyczna: Polski Instytut Evidence Based Medicine"},{"issue":"1","key":"2251_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1681\/ASN.V12197","volume":"12","author":"L Heidet","year":"2001","unstructured":"Heidet L, Arrondel C, Forestier L et al (2001) Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J Am Soc Nephrol 12(1):97\u2013106. https:\/\/doi.org\/10.1681\/ASN.V12197","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2251_CR10","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1086\/302106","volume":"63","author":"E Boye","year":"1998","unstructured":"Boye E, Mollet G, Forestier L et al (1998) Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet 63(5):1329\u20131340. https:\/\/doi.org\/10.1086\/302106","journal-title":"Am J Hum Genet"},{"issue":"4","key":"2251_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/sj.ki.5002365","volume":"72","author":"NPM de Serre","year":"2007","unstructured":"de Serre NPM, Garfa M, Bessi\u00e9res B, No\u00ebl LH, Knebelmann B (2007) Collagen \u03b15 and \u03b12(IV) chain coexpression: analysis of skin biopsies of Alport patients. Kidney Int 72(4):512\u2013516. https:\/\/doi.org\/10.1038\/sj.ki.5002365","journal-title":"Kidney Int"},{"key":"2251_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.12688\/f1000research.9636.1","volume":"6","author":"C Kashtan","year":"2017","unstructured":"Kashtan C (2017) Alport syndrome: facts and opinions. F1000Research 6:50. https:\/\/doi.org\/10.12688\/f1000research.9636.1","journal-title":"F1000Research"},{"issue":"08","key":"2251_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5414\/CNP64085","volume":"64","author":"U Persson","year":"2005","unstructured":"Persson U, Hertz JM, Wieslander J, Segelmark M (2005) Alport syndrome in southern Sweden. Clin Nephrol 64(08):85\u201390. https:\/\/doi.org\/10.5414\/CNP64085","journal-title":"Clin Nephrol"},{"issue":"12","key":"2251_CR14","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1681\/ASN.2013080912","volume":"25","author":"V Morini\u00e8re","year":"2014","unstructured":"Morini\u00e8re V, Dahan K, Hilbert P et al (2014) Improving mutation screening in familial hematuric nephropathies through next generation sequencing. J Am Soc Nephrol 25(12):2740\u20132751. https:\/\/doi.org\/10.1681\/ASN.2013080912","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2251_CR15","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1046\/j.1523-1755.2000.00250.x","volume":"58","author":"M Levy","year":"2000","unstructured":"Levy M, Feingold J (2000) Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int 58(3):925\u2013943. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00250.x","journal-title":"Kidney Int"},{"issue":"6","key":"2251_CR16","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.kint.2020.10.040","volume":"99","author":"AM \u017burowska","year":"2021","unstructured":"\u017burowska AM, Bielska O, Daca-Roszak P et al (2021) Mild X-linked Alport syndrome due to the COL4A5 G624D variant originating in the middle ages is predominant in central\/east Europe and causes kidney failure in midlife. Kidney Int 99(6):1451\u20131458. https:\/\/doi.org\/10.1016\/j.kint.2020.10.040","journal-title":"Kidney Int"},{"issue":"12","key":"2251_CR17","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.3390\/genes13122203","volume":"13","author":"D Hadjipanagi","year":"2022","unstructured":"Hadjipanagi D, Papagregoriou G, Koutsofti C et al (2022) Novel and founder pathogenic variants in X-linked Alport syndrome families in Greece. Genes 13(12):2203. https:\/\/doi.org\/10.3390\/genes13122203","journal-title":"Genes"},{"issue":"5","key":"2251_CR18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2009070784","volume":"21","author":"MR Bekheirnia","year":"2010","unstructured":"Bekheirnia MR, Reed B, Gregory MC et al (2010) Genotype\u2013phenotype correlation in X-linked Alport syndrome. J Am Soc Nephrol 21(5):876\u2013883. https:\/\/doi.org\/10.1681\/ASN.2009070784","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2251_CR19","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2215\/CJN.01000116","volume":"11","author":"N Kamiyoshi","year":"2016","unstructured":"Kamiyoshi N, Nozu K, Fu XJ et al (2016) Genetic, clinical, and pathologic backgrounds of patients with autosomal dominant Alport syndrome. Clin J Am Soc Nephrol 11(8):1441\u20131449. https:\/\/doi.org\/10.2215\/CJN.01000116","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2251_CR20","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/ndt\/gfn681","volume":"24","author":"E Marcocci","year":"2009","unstructured":"Marcocci E, Uliana V, Bruttini M et al (2009) Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome. Nephrol Dial Transpl 24(5):1464\u20131471. https:\/\/doi.org\/10.1093\/ndt\/gfn681","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"2251_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2215\/CJN.04230321","volume":"17","author":"J Savige","year":"2022","unstructured":"Savige J, Lipska-Zietkiewicz BS, Watson E et al (2022) Guidelines for genetic testing and management of Alport syndrome. Clin J Am Soc Nephrol 17(1):143\u2013154. https:\/\/doi.org\/10.2215\/CJN.04230321","journal-title":"Clin J Am Soc Nephrol"},{"key":"2251_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.953643","volume":"9","author":"R G\u00fcnthner","year":"2022","unstructured":"G\u00fcnthner R, Knipping L, Jeruschke S et al (2022) Renal X-inactivation in female individuals with X-linked Alport syndrome primarily determined by age. Front Med 9:953643. https:\/\/doi.org\/10.3389\/fmed.2022.953643","journal-title":"Front Med"},{"issue":"8","key":"2251_CR23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/ki.2011.452","volume":"81","author":"J Temme","year":"2012","unstructured":"Temme J, Peters F, Lange K et al (2012) Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations. Kidney Int 81(8):779\u2013783. https:\/\/doi.org\/10.1038\/ki.2011.452","journal-title":"Kidney Int"},{"issue":"2","key":"2251_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/j.ajkd.2020.03.026","volume":"77","author":"CE Kashtan","year":"2021","unstructured":"Kashtan CE (2021) Alport syndrome: achieving early diagnosis and treatment. Am J Kidney Dis 77(2):272\u2013279. https:\/\/doi.org\/10.1053\/j.ajkd.2020.03.026","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2251_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5858\/133.2.224","volume":"133","author":"M Haas","year":"2009","unstructured":"Haas M (2009) Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis. Arch Pathol Lab Med 133(2):224\u2013232. https:\/\/doi.org\/10.5858\/133.2.224","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"2251_CR26","first-page":"207","volume":"17","author":"A Pierides","year":"2013","unstructured":"Pierides A, Voskarides K, Kkolou M, Hadjigavriel M, Deltas C (2013) X-linked, COL4A5 hypomorphic Alport mutations such as G624D and P628L may only exhibit thin basement membrane nephropathy with microhematuria and late onset kidney failure. Hippokratia 17(3):207\u2013213","journal-title":"Hippokratia"},{"issue":"9","key":"2251_CR27","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1093\/ndt\/gfp158","volume":"24","author":"A Pierides","year":"2009","unstructured":"Pierides A, Voskarides K, Athanasiou Y et al (2009) Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3\/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis. Nephrol Dial Transpl 24(9):2721\u20132729. https:\/\/doi.org\/10.1093\/ndt\/gfp158","journal-title":"Nephrol Dial Transpl"},{"key":"2251_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.18794\/aams\/69243","volume":"71","author":"A Moczulska","year":"2017","unstructured":"Moczulska A, Walkosz J, Zar\u0119bska E et al (2017) Diagnosis of Alport syndrome and thin basement membrane nephropathy in childhood. Ann Acad Medicae Silesiensis 71:73\u201381. https:\/\/doi.org\/10.18794\/aams\/69243","journal-title":"Ann Acad Medicae Silesiensis"},{"issue":"6","key":"2251_CR29","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1046\/j.1523-1755.2002.00379.x","volume":"61","author":"I Longo","year":"2002","unstructured":"Longo I, Porcedda P, Mari F et al (2002) COL4A3\/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. Kidney Int 61(6):1947\u20131956. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00379.x","journal-title":"Kidney Int"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02251-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-025-02251-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02251-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:59:15Z","timestamp":1777564755000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/7\/1831\/8457442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["2251"],"URL":"https:\/\/doi.org\/10.1007\/s40620-025-02251-3","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"assertion":[{"value":"21 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors did not receive support from any organization for the submitted work. The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the Helsinki Declaration and its later amendments or comparable ethical standards. The local ethics committee of Medical University of Lodz (RNN\/148\/23\/KE) approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors followed ethical requirements related to human and animal rights.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"All patients or their legal guardians gave written informed consent to participate in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}}]}}